Unclassified

Efficacy and tolerability of Methylphenidate in children and adolescents with ADHD : A Systematic Review. | ClinicLens

Methylphenidate is the most commonly prescribed first-line stimulant for managing Attention-Deficit/Hyperactivity Disorder (ADHD, yet concerns remain regarding its safety and potential impact on neurodevelopment during critical growth periods. To systematically review the literat

Medical Literature · Updated

← Back to articles
This standalone article is served from the ClinicLens content archive.

If the embedded page does not load in your browser, open it directly.